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The gene encoding Babesia bovis rhoptry-associated protein 1 (RAP-1) was used to develop an enzyme-linked
immunosorbent assay (ELISA) to measure specific antibodies against B. bovis. The B. bovis RAP-1 gene was
subcloned into a baculovirus transfer vector, and the RAP-1 protein was expressed in insect cells infected with
a recombinant baculovirus. The recombinant B. bovis RAP-1 of 65 kDa was detected with anti-RAP-1 mouse
serum by Western blotting, and this recombinant RAP-1 was used as an antigen in the ELISA. The ELISA was
able to differentiate between B. bovis-infected sera and B. bigemina-infected sera or noninfected normal bovine
sera. The results demonstrate that the recombinant RAP-1 expressed in insect cells might be a useful antigen
for the detection of antibodies to B. bovis.
Babesia bovis is a tick-borne hemoprotozoan parasite of
cattle causing babesiosis, a disease of economic importance
to the livestock industry in subtropical and tropical regions
of the world since at least several million cattle globally are
at risk (17). Hence, it is essential to be able to ascertain the
serological status of cattle with regard to B. bovis and have
a rapid, inexpensive, and reliable test for the detection of
the anti-B. bovis-specific antibody. Such a test would have
great benefits in large-scale epidemiological surveys and
lead to eradication. Until now, many serological tests have
been used for the diagnosis of Babesia infection in cattle,
such as the indirect immunofluorescent-antibody test
(IFAT) and the enzyme-linked immunosorbent assay
(ELISA) (3, 26). IFAT has been widely used for the detec-
tion of the anti-B. bovis antibody; however, besides not
being particularly sensitive, IFAT is unsuitable for use with
a large number of serum samples. Furthermore, the results
of IFAT may be influenced by the subjective judgment of the
operator (3, 30). In contrast, ELISA is quite sensitive and
may be easily used to test large numbers of samples (3, 26).
ELISA has previously been evaluated for the detection of
antibodies to B. bovis by use of a native antigen. Its potential
ability has been demonstrated to be a powerful tool for
serological surveys (2, 8, 16, 27), but the poor quality of
antigens and the cross-reaction with B. bigemina have im-
peded its application (3, 9, 26). Recently, an ELISA based
on a recombinant antigen has been significantly developed
(2, 10, 31) because it offers two major advantages: there is a
negligible batch-to-batch variation in the antigen and there
is no need to kill experimental animals for preparation of
the native antigen (2).
The B. bovis rhoptry-associated protein 1 (RAP-1) gene
encoding a 60-kDa merozoite apical membrane polypeptide
was identified by Suraez et al. (23). The function of RAP-1
is poorly understood, but it is believed that rhoptry proteins
play an important role in host cell invasion (21, 22). The
major immunogenic B-cell and T-cell epitopes on RAP-1
are conserved among all strains tested, but they are not
conserved between different species (5, 24). The lack of
extensive differences in RAP-1 among geographically dis-
tinct isolates of B. bovis suggests that RAP-1 should be
considered a candidate antigen in the development of a
diagnostic reagent and subunit vaccine (4, 7, 19). In this
study, the gene encoding B. bovis RAP-1 was expressed in
insect cells by using a baculovirus expression system. Then,
the ELISA based on the recombinant antigen was devel-
oped, and its potential use for the detection of antibodies to
B. bovis in cattle was evaluated.
MATERIALS AND METHODS
Parasites. B. bovis strain Texas was continuously cultured with bovine eryth-
rocytes by using a microaerophilous stationary-phase culturing system (15).
When the level of parasitemia reached 5 to 10%, the infected erythrocytes were
washed three times with phosphate-buffered saline (PBS), and the pellets were
stored at 80°C.
Cloning of RAP-1 gene. B. bovis-infected erythrocyte pellets were suspended in
a DNA extraction buffer (100 mM Tris-HCl [pH 8.0], 1% sodium dodecyl sulfate
[SDS], 0.1 M NaCl, 10 mM EDTA) and digested with proteinase K (100 g/ml)
for 2 h at 55°C. The genomic DNA was then extracted with phenol-chloroform
and precipitated with ethanol. The DNA pellets were suspended in TE buffer (10
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mM Tris-HCl [pH 8.0], 1 mM EDTA) and used as a DNA template for a PCR.
The entire RAP-1 gene was amplified by PCR with two primers, 5-ACGGAT
CCGACAATGAGAATCATT-3 and 5-ACGGATCCAAACGCATCTCATC
AG-3, both of which contained a BamHI site at the 5 end (23). The PCR was
performed in 100 1 of a reaction mixture containing 100 pmol of each primer,
0.5 g of template DNA, 20 M of a mixture of deoxynucleoside triphosphates,
10 l of a 10 buffer, and 2.5 U of Taq Gold polymerase (Perkin-Elmer, Foster
City, Calif.). The PCR amplification was carried out for 30 cycles under the
following conditions. Each cycle consisted of 1 min at 95°C for denaturation (10
min for the first cycle), 1 min at 55°C for annealing, and 2 min at 73°C for
extension. After the PCR was completed, the amplified DNA products were
digested with BamHI. The DNA fragment containing the RAP-1 gene was gel
purified by using a MinElute gel extraction kit (Qiagen Inc., Valencia, Calif.) and
ligated into the BamHI site of a pBluescript SK() cloning vector. The resulting
plasmid was designated pBS/RAP-1. DNA sequencing of the RAP-1 gene was
performed by using an ABI PRISM 377 DNA sequencer (Perkin-Elmer) with a
dye primer cycle sequencing ready-reaction kit (Perkin-Elmer).
Preparation of anti-RAP-1 mouse serum. The RAP-1 gene fragment was
recovered from pBS/RAP-1 after the digestion with BamHI and inserted into the
BamHI site of the Escherichia coli expression vector pGEMEX-2 (Promega
Corp., Madison, Wis.). The vector was designated pGEMEX/RAP-1 and was
used to express the RAP-1 polypeptide as a fusion protein with the bacterio-
phage T7 gene 10 leader peptide in E. coli. Eight-week-old female BALB/c mice
were intraperitoneally immunized with 10 g of the RAP-1 fusion protein in
complete Freund’s adjuvant. On days 14 and 28, the mice were immunized with
the same antigen in incomplete Freund’s adjuvant by intraperitoneal injection.
Sera from the immunized mice were collected 10 days after the final immunization.
Construction of recombinant baculovirus. The RAP-1 gene fragment from
pBS/RAP-1 was inserted into the BamHI site of Bac-to-Bac donor plasmid
pFastBac Ht (Life Technologies, Grand Island, N.Y.). The recombinant donor
plasmid, pFB/RAP-1-Ht, was transformed into DH10Bac competent cells (Life
Technologies). The resultant transposed bacmid containing the RAP-1 gene was
used to cotransfect insect (Spodoptera frugiperda) cells (Sf9 cells) with baculovi-
rus DNA by using liposome reagent (Cellfectin; Life Technologies). After 3 days
of incubation at 27°C, the culture supernatant containing recombinant viruses
expressing the RAP-1 gene, AcRAP-1-Ht, was collected and used to transfect
High five insect cells. The technical methods were in agreement with the instruc-
tion manual of the Bac-to-Bac baculovirus expression system (Life Technolo-
gies). The expression of the RAP-1 gene was confirmed by IFAT and Western
blotting analysis with anti-RAP-1 mouse serum or B. bovis- or B. bigemina-
infected bovine serum.
IFAT. IFAT was performed as described by Avarazed et al. (1).
SDS-polyacrylamide gel electrophoresis (PAGE) and Western blotting anal-
ysis. After 3 days of incubation, High five insect cells infected with recombinant
baculovirus were harvested and centrifuged. The cell pellets were suspended in
PBS, sonicated, and mixed 1:1 with an SDS sample buffer (62.5 mM Tris-HCl
[pH 6.8], 2% SDS, 5% -mercaptoethanol, 10% glycerol, 0.02% bromophenol
blue). The samples were boiled for 5 min prior to electrophoresis in an SDS–10%
polyacrylamide gel, and the gel was then subjected to a Coomassie blue staining
or Western blotting analysis after electrophoresis. For Western blotting analysis,
the proteins were transferred to nitrocellulose membranes (Immobilon transfer
membrane; Millipore) with a semidry blotting apparatus. The membrane was
incubated in a blocking solution (3% skim milk in PBS) for 1 h at room tem-
perature and then with bovine or mouse serum for 1 h. The membranes were
washed three times with 0.05% Tween 20 in PBS (PBST) and incubated with
horseradish peroxidase-labeled goat anti-mouse or anti-bovine immunoglobulin
G (ICN Biomedicals, Inc., Aurora, Ohio) for 1 h. The membrane was washed
three times with PBST and placed into a substrate solution containing 0.5 mg of
diabinobenzidine per ml and 0.005% H2O2 to visualize the antigen-antibody
complexes.
ELISA. High five insect cells infected with AcRAP-1-Ht were washed with
PBS and lysed in a lysis buffer (40 mM Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM
-mercaptoethanol, 20% glycerol, 0.1% Triton X-100, 1 g each of pepstatin A
and lenpeptine per ml). The mixture was placed on ice for 5 min and centrifuged
at 1,500  g for 20 min at 4°C. The supernatant was centrifuged again at 18,000
 g for 30 min and diluted with a coating buffer (50 mM carbonate-bicarbonate
buffer [pH 9.6]) as an ELISA antigen to a final concentration of 10 g/ml. Each
well of 96-well plates (Nalge Nunc International, Roskilde, Denmark) was
coated with 50 1 of antigen overnight at 4°C. On the following day, the plates
were washed once with PBST and incubated with 100 1 of a blocking solution
(3% skim milk in PBS) for 1 h at 37°C. After one wash with PBST, 50 1 of an
individual test serum sample diluted to 1:200 with the blocking solution was
added to each well and the plate was incubated for 1 h at 37°C. The plates were
washed six times with PBST and then incubated for 1 h at 37°C with 50 1 of
horseradish peroxidase conjugate (ICN Biomedicals) that had been diluted to
1:4,000 with the blocking solution. The plates were washed as described above,
and then 50 1 of a substrate solution [0.1 M citric acid, 0.2 M sodium phosphate,
0.003% H2O2, 0.3 mg of 2,2-azide-bis(3-ethylbenzthiazoline-6-sulfonic acid)
(Sigma Chemical) per ml] was added to each well. After 1 h of incubation at
room temperature the optical density (OD) was measured at a wavelength of 415
nm.
Sera. Serum samples from cattle experimentally infected with B. bovis or B.
bigemina and negative serum samples from healthy cattle were kindly provided
by individuals from Washington State University (Pullman, Wash.) and Texas
A&M University (College Station, Tex.). Field serum samples from 201 cattle in
Brazil and 283 cattle in Mongolia were also examined.
RESULTS
Cloning of RAP-1 gene from B. bovis. The RAP-1 gene of B.
bovis was amplified from the Texas strain by the PCR method.
As a result, a 1,695-bp DNA fragment was amplified from the
B. bovis genomic DNA and inserted into pBluescript SK().
The identify of the PCR product was proved by sequencing.
The DNA sequence data for the fragment were compared with
the original RAP-1 sequence data (GenBank accession no.
AF027149), and there was no variation in the nucleotide se-
quence. The RAP-1 gene was expressed as a gene 10 fusion
protein in E. coli, and anti-RAP-1 mouse serum was prepared
from the immunized mice with the recombinant gene 10 fusion
FIG. 1. IFAT analysis of mouse anti-B. bovis RAP-1 antibody. Noninfected bovine erythrocytes (A) B. bovis-infected bovine erythrocytes (B),
and B. bigemina-infected bovine erythrocytes (C) were reacted with mouse anti-B. bovis RAP-1 antibody.
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protein. The antiserum reacted with B. bovis but not with
either B. bigemina or normal bovine erythrocytes (Fig. 1).
Construction of recombinant baculovirus. To obtain suf-
ficient amounts of the soluble RAP-1 antigen for ELISA, we
constructed a recombinant baculovirus capable of expressing
the B. bovis RAP-1 gene. High five insect cells were infected
with recombinant baculovirus AcRAP-1-Ht. After incubation
for 3 days, the entire cell extract was analyzed by SDS-PAGE
(10% polyacrylamide). A major polypeptide band with a mo-
lecular mass of 65 kDa was identified (data not shown). The
molecular mass of the recombinant protein was larger than
that of the native RAP-1 protein due to the six-histidine affinity
tag (data not shown). A 65-kDa polypeptide was overproduced
by the AcRAP-1-Ht-infected cells, and the protein expressed
was identified as the B. bovis RAP-1 gene product by its reac-
tion with anti-RAP-1 mouse serum by Western blotting anal-
ysis (Fig. 2). In contrast, no band was detected from nonin-
fected cell extracts. The AcRAP-1-Ht-infected cells were also
examined by IFAT with serum experimentally infected with B.
bovis or B. bigemina. Specific fluorescence was observed in
AcRAP-1-Ht-infected cells with B. bovis-infected bovine se-
rum but not in mock-infected cells (Fig. 3).
Detection of antibody to B. bovis in cattle by ELISA with
recombinant RAP-1 as antigen. In order to assess the ability
of ELISA to detect anti-B. bovis-specific antibody on the basis
of recombinant RAP-1 expression in infected cells, a total of 31
reference bovine serum samples were tested by ELISA. All 14
positive samples with antibodies against B. bovis had ODs
0.3, whereas all 4 positive samples with antibodies against B.
bigemina and 13 negative control samples had ODs 0.3 (Fig.
4). Field serum samples from 201 cattle in Brazil and 283 cattle
in Mongolia were tested by ELISA; 19 of 201 (9.4%) samples
from Brazil (Table 1) and 101 of 283 (35.7%) samples from
Mongolia (Table 2) showed positive responses (the cutoff was
chosen as an OD 0.3). The ages of the cattle varied from 1 to
10 years. The seroprevalence of antibodies to B. bovis in Brazil
was low in animals of all age groups (Table 1), whereas the
majority of the cattle in Mongolia in which antibodies to B.
bovis were the most seroprevalent were in the 1- to 2-year-old
age group (58.7%) (Table 2).
DISCUSSION
RAP-1 is a strong immunogenic protein of B. bovis (5).
Vaccination of target animals with recombinant RAP-1 had
FIG. 2. Western blot analysis of B. bovis RAP-1 expressed in High
five insect cells by using mouse anti-B. bovis RAP-1 antibody or bovine
anti-B. bigemina antibody. High five insect cells (lane 1) and High five
insect cells infected with AcRAP-1-Ht (lane 2) were reacted with
mouse anti-B. bovis RAP-1 antibody. High five insect cells infected
with AcRAP-1-Ht (lane 3) were reacted with bovine anti-B. bigemina
antibody.
FIG. 3. IFAT analysis of B. bovis RAP-1 expressed in High five insect cells by using bovine anti-B. bovis antibody or bovine anti-B. bigemina
antibody. High five insect cells (A) and High five insect cells infected with AcRAP-1-Ht (B) were reacted with bovine anti-B. bovis antibody. High
five insect cells (C) and High five insect cells infected with AcRAP-1-Ht (D) were reacted with bovine anti-B. bigemina antibody.
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been shown to give protection against a virulent heterologous
strain (29). Bovine B. bovis-immune serum can immunopre-
cipitate the whole recombinant RAP-1 or a product of the
RAP-1 deletion clone (25). Therefore, it was considered a
candidate antigen for use in vaccine development (4, 7, 19) and
to have potential as a diagnostic antigen for the detection of
anti-B. bovis antibodies in cattle. In the present study, we
expressed recombinant RAP-1 in High five insect cells by using
a baculovirus expression system and evaluated it to determine
its diagnostic potential in an ELISA for the detection of anti-
bodies to B. bovis in cattle.
The ELISA based on recombinant RAP-1 was able to dif-
ferentiate clearly between B. bovis-infected sera and B. bigemi-
na-infected sera or noninfected normal bovine sera at an OD
at 415 nm (OD415) of 0.3, which was the cutoff, but B. bigemi-
na-infected sera cross-reacted with the recombinant RAP-1
protein at an OD415 of about 0.2. However, the number of
bovine serum samples tested was small, and further evaluation
with a large number of bovine serum samples will be necessary.
This cross-reaction may be due to the high degree of sequence
identity in the first 300 amino acids of B. bovis RAP-1 and B.
bigemina p58 (24). Suraez et al. (25) reported that antibodies in
serum from cattle immune to B. bigemina did not react with
whole RAP-1 or the product of RAP-1 deletion clone F2
(amino acids 235 to 565) but reacted with the product of
RAP-1 deletion clone F1 (amino acids 1 to 235). This is similar
to our result that B. bigemina-infected bovine serum did not
react with recombinant RAP-1 protein by Western blot anal-
ysis or IFAT. The cross-reactive epitopes are poorly immuno-
genic and inaccessible in whole RAP-1 (25).
A baculovirus expression system has been used to express
proteins of protozoan parasites (6, 18, 31). It has many advan-
tages over other expression systems, such as a high level of
expression efficacy and the ability to preserve the biological
properties of the recombinant protein (12, 14). We demon-
strated that the recombinant RAP-1 expressed in High five
insect cells by the baculovirus expression system can be used as
an antigen in an ELISA for the detection of the anti-B. bovis
antibodies in cattle, but we still need to consider the cross-
reaction with B. bigemina. Next, we are going to construct a
deletion clone of B. bovis RAP-1 in order to get a more specific
recombinant antigen with no cross-reactivity with B. bigemina.
Several recent studies performed to develop an ELISA with a
recombinant antigen for the detection of anti-Babesia antibod-
ies have shown satisfactory results (2, 10, 13, 31). In the present
study, the cost of the assay for each sample tested in duplicate
was estimated to be less than US$0.08, and this low cost of
performance may result in a promising serodiagnostic tool for
the detection of B. bovis infections in developing countries.
Therefore, the use of a recombinant antigen in an ELISA may
lead to the development of highly standardized diagnostic tests
based on well-defined, reproducible, and inexpensive antigens
for the detection of babesiosis.
Although bovine babesiosis is widespread in Brazil (20), the
mean prevalence of samples positive for antibodies to B. bovis
was only 9.4% in this study. The seroprevalence of antibodies
to B. bovis was low in all age groups. This low prevalence is
probably due to some differences in the distribution of the
disease among the different regions of the country, which is
attributed to the distribution of the tick vector and tick control
programs. On the contrary, the mean prevalence of samples for
positive B. bovis in Mongolia was found to be high (35.7%),
especially in the 1- to 2-year-old age group (58.7%). The re-
sults from this serological survey suggest that bovine babesiosis
caused by B. bovis is probably endemic in Mongolia. In areas of
endemicty, an antibody to B. bovis can be detected in neonatal
FIG. 4. Value from ELISA with recombinant RAP-1 with experi-
mentally infected bovine sera. Lane 1, B. bovis-infected bovine sera;
lane 2, B. bigemina-infected bovine sera; lane 3, noninfected bovine
sera.
TABLE 1. Prevalence of antibodies against B. bovis in Brazil at
various ages
Age (yr) No. of samples No. (%) ofseropositive samples
1–2 130 14 (10.8)
3–4 17 1 (5.9)
5–6 26 1 (3.8)
7–10 28 3 (10.7)
Total 201 19 (9.4)
TABLE 2. Prevalence of antibodies against B. bovis in Mongolia at
various ages
Age (yr) No. of samples No. (%) ofseropositive samples
1–2 75 44 (58.7)
3–4 90 29 (32.2)
5–6 59 17 (28.8)
7–10 49 11 (22.4)
Total 283 101 (35.7)
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calves and considered of maternal origin (11, 28). A prominent
feature of the pattern of antibodies against this parasite was a
fall in antibody levels during the first months of life and a rise
in antibody titers in the first year of life, which is probably in
response to tick-transmitted infection (28). However, further
surveys with more samples from additional populations will be
necessary to evaluate the status of B. bovis infection in Brazil
and Mongolia.
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